DECRYPTION – In receivership, this symbol of health independence is looking for a buyer.
The countdown is on for Carelide. It remains until January 13 to the northern manufacturer of medical devices, in receivership since November, to find a buyer. The hearing at the Lille Commercial Court has been set for January 25.
It is the last French producer of infusion bags (anti-inflammatories, paracetamol, antibiotics) which is now threatened with extinction. A company that had been in the spotlight during the Covid, its products used to treat patients on drips. On a visit to the site, Agnès Pannier-Runacher, who at the time was Deputy Minister in charge of Industry, had granted it in the name of the “health sovereignty» an aid of 5 million euros (out of a program of 12 million euros of investment in total) in order to contribute to the increase of its production capacities and the automation of certain processes.
The state is mobilizing
The coup de grace for the company, which employs 420 employees on permanent contracts and 130 temporary workers and carries out…
This article is for subscribers only. You have 69% left to discover.
Cultivating your freedom is cultivating your curiosity.
Keep reading your article for €0.99 for the first month
Already subscribed? Login